Canine Prostate Stimulates Osteoblast Function Using the Endothelin Receptors

Prostate

Volumn 59, Issue 2, 2004, Pages 148-156

  LeRoy, Bruce E ^a   Sellers, Rani S ^b   Rosol, Thomas J ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Alkaline phosphatase; Calvarium; Dog; Endothelin receptor antagonist; Osteoblast; Prostate

Indexed keywords

ALKALINE PHOSPHATASE; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; INDOMETACIN; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE RELATED PROTEIN ANTIBODY; PROSTAGLANDIN SYNTHASE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; BONE METASTASIS; CALVARIA; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DOG; DOSE RESPONSE; ENZYME ACTIVITY; GROWTH REGULATION; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; MALE; METASTASIS POTENTIAL; MUSCLE; NONHUMAN; OSTEOBLAST; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; RAT; RECEPTOR BINDING; RELIABILITY; REPRODUCIBILITY; SALIVARY GLAND;

ANIMALS; BONE NEOPLASMS; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DOGS; ENDOTHELINS; EPITHELIAL CELLS; HUMANS; MALE; NEOPLASM METASTASIS; OSTEOBLASTS; OSTEOGENESIS; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ENDOTHELIN; REPRODUCIBILITY OF RESULTS;

EID: 1842782770     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10370     Document Type: Article

References (43)

1. Cunha CR, Donjacour AA, Hayward SW, Thomson AA, Marker PC, Abate-Shen C, Shen M, Dahiya R. Cellular and molecular biology of prostatic development. In: Kantoff PW, Carroll PR, D'Amico AV, editors. Prostate cancer: Principles and practice. Philadelphia: Lippincott Williams & Wilkins; 2002. pp 16-28.
2. Guise TA, Mundy GR. Cancer and bone. Endocr Rev 1998;19:18-54.
3. Chirgwin JM, Guise TA. Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Crit Rev Eukaryot Gene Expr 2000;10:159-178.
4. Nelson JB, Hedican SP, George DJ, Reddi AH, Piantadosi S, Eisenberger MA, Simons JW. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1995;1:944-949.
5. Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS. Prostate carcinoma skeletal metastases: Cross-talk between tumor and bone. Cancer Metastasis Rev 2001;20:333-349.
6. Yi B, Williams PJ, Niewolna M, Wang Y, Yoneda T. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res 2002;62:917-923.
7. Fagan KA, McMurtry IF, Rodman DM. Role of endothelin-1 in lung disease. Respir Res 2001;2:90-101.
8. Davenport AP. International union of pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 2002;54:219-226.
9. Nelson JB, Carducci MA. The role of endothelin-1 and endothelin receptor antagonists in prostate cancer. BJU Int 2000; 85(Suppl 2):45-48.
10. Nelson JB, Nguyen SH, Wu-Wong JR, Opgenorth TJ, Dixon DB, Chung LW, Inoue N. New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade. Urology 1999;53:1063-1069.
11. Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, Buhler KR, Vessella RL. Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells. Prostate 2002;52:20-33.
12. Chiao JW, Moonga BS, Yang YM, Kancherla R, Mittelman A, Wu-Wong JR, Ahmed T. Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption. Br J Cancer 2000;83:360-365.
13. Kitten AM, Andrews CJ. Endothelin-1 expression in long-term cultures of fetal rat calvarial osteoblasts: Regulation by BMP-7. J Cell Physiol 2001;187:218-225.
14. Hagiwara H, Naruse M, Adachi C, Inoue A, Hiruma Y, Otsuka E, Naruse K, Demura H, Hirose S. Ipriflavone down-regulates endothelin receptor levels during differentiation of rat calvarial osteoblast-like cells. J Biochem (Tokyo) 1999;126:168-173.
15. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994;368:703-710.
16. Stern PH, Tatrai A, Semler DE, Lee SK, Lakatos P, Strieleman PJ, Tarjan G, Sanders JL. Endothelin receptors, second messengers, and actions in bone. J Nutr 1995;125:2028S-2032S.
17. Tatrai A, Foster S, Lakatos P, Shankar G, Stern PH. Endothelin-1 actions on resorption, collagen and noncollagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures. Endocrinology 1992;131:603-607.
18. Walden PD, Ittmann M, Monaco ME, Lepor H. Endothelin-1 production and agonist activities in cultured prostate-derived cells: Implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia. Prostate 1998;34:241-250.
19. Ishizaka K, Azuma H, Matsubara O, Kitahara S, Oshima H. Production of endothelin by canine prostatic epithelial cells and its stimulatory effects on their growth. J Androl 1999;20:529-536.
20. Kopetz ES, Nelson JB, Carducci MA. Endothelin-1 as a target for therapeutic intervention in prostate cancer. Invest New Drugs 2002;20:173-182.
21. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 1994;15:439-461.
22. Watts NB. Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999;45:1359-1368.
23. Magnusson P, Larsson L, Englund G, Larsson B, Strang P, Selin-Sjogren L. Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain. Clin Chem 1998;44:1621-1628.
24. LeRoy BE, Bahnson RR, Rosol TJ. Canine prostate induces new bone formation in mouse calvaria: A model of osteoinduction by prostate tissue. Prostate 2002;50:104-111.
25. Blomme EA, Sugimoto Y, McCauley LK, Lin YC, Capen CC, Rosol TJ. Stromal and epithelial cells of the canine prostate express parathyroid hormone-related protein, but not the PTH/ PTHrP receptor. Prostate 1998;36:110-120.
26. Aubin JE. Osteoprogenitor cell frequency in rat bone marrow stromal populations: Role for heterotypic cell-cell interactions in osteoblast differentiation. J Cell Biochem 1999;72:396-410.
27. Zach D, Windischhofer W, Leis HJ. Endothelin and sarafotoxin-induced receptor-mediated calcium mobilization in a clonal murine osteoblast-like cell line, MC3T3-E1/B. Bone 2001;28:595-602.
28. Leav I, Schelling SH, Merk FB. Age-related and sex hormone-induced changes in the canine prostate. In: Mohr U, Carlton WW, Dungworth DL, Benjamin SA, Capen CC, Hahn FF, editors. Pathobiology of the aging dog. Ames: Iowa State University Press; 2001. pp 310-329.
29. Ding VD, Moller DE, Feeney WP, Didolkar V, Nakhla AM, Rhodes L, Rosner W, Smith RG. Sex hormone-binding globulin mediates prostate androgen receptor action via a novel signaling pathway. Endocrinology 1998;139:213-218.
30. Boehringer Mannheim System Application Sheet, Alkaline Phosphatase. 1998.
31. Rosol TJ, Steinmeyer CL, McCauley LK, Merryman JI, Werkmeister JR, Grone A, Weckman MT, Swayne DE, Capen CC. Studies on chicken polyclonal anti-peptide antibodies specific for parathyroid-hormone related protein (1-36). Vet Immunol Immunopathol 1993;35:321-337.
32. Wu-Wong JR, Dixon DB, Chiou WJ, Sorensen BK, Liu G, Jae H-S, Tasker A, von Geldern TW, Winn M, Opgenorth TJ. Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086, and A-192621: In vitro studies. Clin Sci 2002;103(Suppl 48):107S-111S.
33. Miao D, Scutt A. Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J Histochem Cytochem 2002;50:333-340.
34. Wu-Wong JR, Dixon DB, Opgenorth TJ. Effects of human plasma proteins on endothelin binding and function. J Cardiovasc Pharmacol 1998;31(Suppl 1):S164-S168.
35. Wu-Wong JR, Dixon DB, Chiou WJ, Opgenorth TJ. Endothelin receptor antagonists: Effect of serum albumin on potency and comparison of pharmacological characteristics. J Pharmacol Exp Ther 1997;281:791-798.
36. Wu-Wong JR. Using receptor antagonists in binding studies to characterize a mammalian endothelin receptor. Methods Mol Biol 2002;206:71-91.
37. Tsukahara H, Hori C, Hiraoka M, Yamamoto K, Ishii Y, Mayumi M. Endothelin subtype A receptor antagonist induces osteopenia in growing rats. Metabolism 1998;47:1403-1407.
38. Fizazi K, Yang J, Daliani D, Logothetis C, Peleg S, Navone NM. The effects of endothelin-1 and ABT-627, an endothelin-1 antagonist, in an in vitro model of bone metastases from prostate cancer. Proc Am Assoc Cancer Res 2001;42:231.
39. Pilbeam CC, Harrison JR, Raisz LG. Prostaglandins and bone metabolism. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego: Academic Press; 2002. pp 979-994.
40. Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, Vasavada RC, Weir EC, Broadus AE, Stewart AF. Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 1996;76:127-173.
41. Barengolts EI, Lathon PV, Kukreja SC. Effect of various parathyroid hormone-related proteins (PTHrP) fragments on bone resportion and formation in vivo. J Bone Miner Res 1997; 11(Supl 1):S202.
42. Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 1990;4:3111-3123.
43. Majeska RJ, Gronowicz GA. Current methodologic issues in cell and tissue culture. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego, CA: Academic Press; 2002. pp 1529-1541.